Auxilium Pharma (AUXL) Posts Q3 loss of $0.34
More News related to AUXL
- Bank of America Resumes Coverage on Auxilium Pharmaceuticals (AUXL) with a Buy
- Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare Conference
- Auxilium Pharmaceuticals, Inc. (AUXL) Chief Executive Officer and President to Ring The NASDAQ Stock Market Closing Bell
- Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
More News related to Earnings
- After-Hours Movers 11/24: QADI, JCG, ASYS Higher; DRAM, CWTR Lower
- Trading Radar for 11/25: Deere & Co. (DE), Tiffany & Co. (TIF), Conn's (CONN) Report
- Afternoon ETF Check: SMH Up; XLF, TAN, EWJ Down
- Unusual 11 Mid-Day Movers 11/24: IWA, DRAM, ABG, TIXC Higher; WH, WMG, ABIO, NYNY Lower
- Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reports Q3 loss of $0.34, versus the analyst estimate of ($0.31). Revenue for the quarter was $42.10 million, which compares to the estimate of $41.23 million.
Related Categories
EarningsStocks Mentioned
+0.14Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
